Welcure Drugs & Pharmaceuticals Quarterly Results for Trading Insights
WELCURE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹2 Cr
QMarch 2025
Welcure Drugs & Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹27 Cr in March 2025 (+0.0% vs March 2025)
- Net Profit of ₹2 Cr in March 2025 (+0.0% vs March 2025)
- EBITDA of ₹3 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 4.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.36 in March 2025 (+0.0% vs March 2025)
Welcure Drugs & Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 390 | 27 | 0 | 0 | 0 | 1344.4% | - |
| Net Profit (₹ Cr) | 34 | 2 | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 45 | 3 | 0 | 0 | 0 | - | - |
| EPS (₹) | 3.20 | 0.36 | -0.13 | 0.08 | 0.02 | - | - |
| Operating Margin (%) | 10.0% | 4.0% | 0.0% | 0.0% | 22.0% | - | - |
Welcure Drugs & Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Welcure Drugs & Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Welcure Drugs & Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Welcure Drugs & Pharmaceuticals
Additional stock information and data for WELCURE
Revenue Trend (₹ Cr)
March 2023
0
March 2024
0
March 2025
27
2026
390
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
0
March 2025
2
2026
34
Operating Margin Trend (%)
March 2023
0.0%
March 2024
0.0%
March 2025
4.0%
2026
10.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Welcure Drugs & Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores